Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Yunnan Baiyao Acquires Two Small Pharmas

publication date: Nov 29, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Yunnan Baiyao Group Co., Ltd. will buy two smaller pharmaceutical companies for a total of 50 million RMB ($6.8 million). Yunnan will pay 37 million RMB ($5 million) for Kunming Xingzhong Pharmaceutical Co. and 13 million RMB ($1.8 million) for Kunming Yunjian Pharmaceutical Co. The reason for the purchase seems to be the added production capacity the acquisitions would bring, because the ongoing business of each company adds only an extremely small fraction onto the business of Yunnan Baiyao, which has a market cap of $2 billion.  More details...

Stock Symbol: (SZSE: 000538)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners